Literature DB >> 1948295

Prodromal signs of relapse in schizophrenia.

N Tarrier1, C Barrowclough, J S Bamrah.   

Abstract

Fifty-six patients who were hospitalised for a schizophrenic episode were followed up for nine months after discharge. The Psychiatric Assessment Scale (PAS, Krawiecka et al., 1977) was administered at monthly intervals during this period. Twenty-three patients relapsed of which data were available for sixteen. In these sixteen patients who relapsed comparisons were made of the PAS symptoms between the month prior to relapse and the month preceding this. Sixteen patients who did not relapse were randomly matched with the relapsing patients and an index point comparable in time to relapse onset in the matched relapsed patient was identified. Comparisons were made on the PAS symptoms using a repeated measures ANOVA to compare relapsers and non relapsers on the month prior to relapse and the month which preceded this. Discriminant function analysis was used to predict relapse by analysis of those PAS symptoms which showed an increase in the month before relapse. This suggested that the measures of depression and hallucinations significantly increased in the month prior to relapse compared to the preceding month in relapsers but not non-relapsers. The results of this study closely agree with previous published results even though there were some differences between studies in the patient samples.

Entities:  

Mesh:

Year:  1991        PMID: 1948295     DOI: 10.1007/bf00795207

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  11 in total

1.  Treating prodromal episodes to prevent relapse in schizophrenia.

Authors:  M I Herz; W Glazer; M Mirza; M Mostert; H Hafez
Journal:  Br J Psychiatry Suppl       Date:  1989-07

2.  Dysphoric and depressive symptoms in chronic schizophrenia.

Authors:  S R Hirsch; A G Jolley; T R Barnes; P F Liddle; D A Curson; A Patel; A York; S Bercu; M Patel
Journal:  Schizophr Res       Date:  1989 May-Jun       Impact factor: 4.939

3.  Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation.

Authors:  M Birchwood; J Smith; F Macmillan; B Hogg; R Prasad; C Harvey; S Bering
Journal:  Psychol Med       Date:  1989-08       Impact factor: 7.723

4.  Prodromal signs and symptoms of schizophrenic relapse.

Authors:  K L Subotnik; K H Nuechterlein
Journal:  J Abnorm Psychol       Date:  1988-11

5.  Depression 'revealed' in schizophrenia.

Authors:  S R Hirsch
Journal:  Br J Psychiatry       Date:  1982-04       Impact factor: 9.319

6.  Coping with symptoms of relapse in schizophrenia.

Authors:  S Kumar; R Thara; S Rajkumar
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

7.  Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.

Authors:  A G Jolley; S R Hirsch; A McRink; R Manchanda
Journal:  BMJ       Date:  1989-04-15

8.  Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.

Authors:  M I Herz; H V Szymanski; J C Simon
Journal:  Am J Psychiatry       Date:  1982-07       Impact factor: 18.112

9.  Early insight and the management of schizophrenic decompensation.

Authors:  D W Heinrichs; B P Cohen; W T Carpenter
Journal:  J Nerv Ment Dis       Date:  1985-03       Impact factor: 2.254

10.  Stages of onset of schizophrenic psychosis.

Authors:  J P Docherty; D P Van Kammen; S G Siris; S R Marder
Journal:  Am J Psychiatry       Date:  1978-04       Impact factor: 18.112

View more
  11 in total

1.  Depression in the long-term course of schizophrenia.

Authors:  Wolfram an der Heiden; Regina Könnecke; Kurt Maurer; Daniel Ropeter; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

2.  Acceptance-based Behavior Therapy for Depression With Psychosis: Results From a Pilot Feasibility Randomized Controlled Trial.

Authors:  Brandon A Gaudiano; Andrew M Busch; Susan J Wenze; Kathryn Nowlan; Gary Epstein-Lubow; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2015-09       Impact factor: 1.325

Review 3.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  An open trial of a new acceptance-based behavioral treatment for major depression with psychotic features.

Authors:  Brandon A Gaudiano; Kathryn Nowlan; Lily A Brown; Gary Epstein-Lubow; Ivan W Miller
Journal:  Behav Modif       Date:  2012-12-06

5.  Prodromal symptoms in manic depressive psychosis.

Authors:  J A Smith; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-10       Impact factor: 4.328

6.  Patterns of stress in schizophrenia.

Authors:  Julia D Betensky; Delbert G Robinson; Handan Gunduz-Bruce; Serge Sevy; Todd Lencz; John M Kane; Anil K Malhotra; Rachel Miller; Joanne McCormack; Robert M Bilder; Philip R Szeszko
Journal:  Psychiatry Res       Date:  2008-06-02       Impact factor: 3.222

7.  A cluster randomised controlled trial of patient-held medical records for people with schizophrenia receiving shared care.

Authors:  Helen Lester; Teresa Allan; Sue Wilson; Sue Jowett; Lesley Roberts
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

8.  Trajectories and changes in individual items of positive and negative syndrome scale among schizophrenia patients prior to impending relapse.

Authors:  Dai Wang; Srihari Gopal; Susan Baker; Vaibhav A Narayan
Journal:  NPJ Schizophr       Date:  2018-06-20

9.  mHealth-Assisted Detection of Precursors to Relapse in Schizophrenia.

Authors:  Benjamin Buck; Kevin A Hallgren; Andrew T Campbell; Tanzeem Choudhury; John M Kane; Dror Ben-Zeev
Journal:  Front Psychiatry       Date:  2021-05-31       Impact factor: 4.157

Review 10.  The nature of relapse in schizophrenia.

Authors:  Robin Emsley; Bonginkosi Chiliza; Laila Asmal; Brian H Harvey
Journal:  BMC Psychiatry       Date:  2013-02-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.